DUBLIN – By the brutal, binary calculations of Wall Street, Olivier Brandicourt's four-year stint as CEO of Sanofi SA cannot be regarded as a success. The Paris-based pharma firm's stock is down by 18% over the period between April 1, 2015, the day before he took office, and June 6, 2019, the last day prior to the announcement of his departure.